Last reviewed · How we verify

NCT06945692

Assessment of Accuracy and Aesthetics Following Automated Mandibular Defect Reconstruction Using AI

Not yet recruiting NA Last updated 25 April 2025
What this trial tests

NA trial testing patient specific reconstruction plates in Mandibular Tumor in 4 participants. Not yet recruiting.

Timeline
1 May 2025
Primary endpoint
1 April 2026
1 May 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment4
Start date1 May 2025
Primary completion1 April 2026
Estimated completion1 May 2026

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 55, any sex, with Mandibular Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Aim of the study is to evaluate Accuracy of automated mandibular defect reconstruction using Artificial intelligence and assessing impact on aesthetic and occlusion outcomes using patient-specific reconstruction plates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06945692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing